Oleic Acid

Oleic Acid

SCHEMBL5082037

CCCCCCCCC=CCCCCCCCC(=O)[O-].CCCCCCCCC=CCCCCCCCC(=O)[O-].CCCCCCCCC=CCCCCCCCC(=O)[O-].[La+3]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP3 P05413 9/20 0.96
▸ TERT O14746 3/20 0.66
▸ MAPT P10636 2/20 0.66
▸ BLM P54132 2/20 0.66
▸ HSD17B10 Q99714 2/20 0.66
▸ FABP4 P15090 2/20 0.66
▸ GMNN O75496 1/20 0.66
▸ USP2 O75604 1/20 0.66
▸ LMNA P02545 1/20 0.66
▸ CYP1A2 P05177 1/20 0.66
▸ POLB P06746 1/20 0.66
▸ CYP2C9 P11712 1/20 0.66
▸ ALOX15 P16050 1/20 0.66
▸ APEX1 P27695 1/20 0.66
▸ CYP2C19 P33261 1/20 0.66
▸ RECQL P46063 1/20 0.66
▸ NPSR1 Q6W5P4 1/20 0.66
▸ DUSP3 P51452 1/20 0.66
▸ MMP2 P08253 1/20 0.66
▸ FAAH O00519 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29378160 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Oleic Acid SCHEMBL5082025 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Palmitoleic Acid SCHEMBL22501044 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Vaccenic Acid SCHEMBL29378361 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
SCHEMBL29377917 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Oleic Acid SCHEMBL233564 0.98 FABP3 (1.00) FABP3TERTMAPTBLMHSD17B10
Oleic Acid SCHEMBL233567 0.98 FABP3 (1.00) FABP3TERTMAPTBLMHSD17B10
Oleic Acid SCHEMBL25310368 0.96 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
SCHEMBL25400903 0.96 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Palmitoleic Acid SCHEMBL22501207 0.96 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024061281-A1 KIT FOR DETECTING PROSTATE CANCER AND USE THEREOF, AND KIT FOR DETECTING BLADDER CANCER AND USE THEREOF 宁波大学附属第一医院 2024-03-28 — — WO claimed
US-11332661-B2 Modified perovskite quantum dot material, fabricating method thereof, and display device WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2022-05-17 — — US claimed
US-20210071072-A1 MODIFIED PEROVSKITE QUANTUM DOT MATERIAL, FABRICATING METHOD THEREOF, AND DISPLAY DEVICE WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-03-11 — — US claimed
WO-2019218449-A1 PREPARATION METHOD FOR PEROVSKITE QUANTUM DOT AND PEROVSKITE QUANTUM DOT SOLUTION 武汉华星光电半导体显示技术有限公司 (CN) 2019-11-21 — — WO claimed
US-12403118-B1 Cancer treatments using modified fatty acids and the carriers to administer them Zetagen Therapeutics, Inc. (US) 2025-09-02 — — US disclosed
CN-119659132-A High-load full-color transparent display film and preparation method and application thereof 济南大学 2025-03-21 — — CN disclosed
CN-118063895-A Extrusion-blowing transparent polypropylene resin and preparation method thereof 中国神华煤制油化工有限公司 2024-05-24 — — CN disclosed
CN-113631263-B Nanoparticle-supported compositions and precursors, methods of making and methods of converting synthesis gas 埃克森美孚化学专利公司 2024-05-14 — — CN disclosed
WO-2024061281-A1 KIT FOR DETECTING PROSTATE CANCER AND USE THEREOF, AND KIT FOR DETECTING BLADDER CANCER AND USE THEREOF 宁波大学附属第一医院 2024-03-28 — — WO disclosed
US-20240010579-A1 Processes for Making Linear Alpha-Olefins EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-01-11 — — US disclosed
US-11857954-B2 Supported nanoparticle compositions and precursors, processes for making the same and syngas conversion processes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2024-01-02 — — US disclosed
EP-3405552-B1 LANTHANIDE BASED UPCONVERTING MICRORODS AND APPLICATION THEREOF COUNCIL SCIENT IND RES (IN) 2023-03-01 — — EP disclosed
CN-105295243-A Hydrotalcite-oleic acid rare earth composite environmental protection stabilizer for PVC, and preparation method thereof HWASU CORP 2016-02-03 — — CN disclosed
EP-2709954-A1 METHOD FOR PREPARING METAL OXIDE NANOPARTICLES King Saud University (SA) 2014-03-26 — — EP disclosed
EP-1972644-B1 METHOD FOR PRODUCING CIS-1,4 DIENE RUBBER, CATALYST, RUBBER OTKRYTOE AKTSIONERNOE OBSCHESTVO EFREMOVSKY ZD SINT KAUCHUKA (RU) 2013-03-06 — — EP disclosed
WO-2012155931-A1 METHOD FOR PREPARING METAL OXIDE NANOPARTICLES KING SAUD UNIVERSITY (SA) 2012-11-22 — — WO disclosed
EP-1972644-A1 METHOD FOR PRODUCING CIS-1,4 DIENE RUBBER, CATALYST, RUBBER Otkrytoe Aktsionernoe Obschestvo 'Efremovsky Zavod Sinteticheskogo Kauchuka' (RU) 2008-09-24 — — EP disclosed
CN-1351618-A Method for producing thermoplastic molding materials using rubber solutions BAYER AG (DE) 2002-05-29 — — CN disclosed
US-5004720-A Mixing Metal Acetylacetonates, Hydrolyzing, Sintering MITSUBISHI DENKI KABUSHIKI KAISHA (JP) 1991-04-02 — — US disclosed
US-4073743-A Process for preparing an emulsion MERCK & CO., INC. (US) 1978-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210071072-A1 MODIFIED PEROVSKITE QUANTUM DOT MATERIAL, FABRICATING METHOD THEREOF, AND DISPLAY DEVICE RAB5IF, PTPN3, CD2 FABP3 1159/4885TERT 141/4885MAPT 2863/4885
US-12403118-B1 Cancer treatments using modified fatty acids and the carriers to administer them PAK4, FFAR4, PIK3R4 FABP3 567/4885TERT 2519/4885MAPT 4419/4885
US-11332661-B2 Modified perovskite quantum dot material, fabricating method thereof, and display device RAB5IF, PTPN3, CD2 FABP3 1159/4885TERT 141/4885MAPT 2863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback